The Discounted Cash Flow (DCF) valuation of Epizyme Inc (EPZM) is (349.59) USD. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on DCF is -23881.5%.
Based on the latest price of 1.47 USD and our DCF valuation, Epizyme Inc (EPZM) is a sell. selling EPZM stocks now will result in a potential gain of 23881.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.9% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (702.54) - (235.65) | (349.59) |
| Upside | -47891.5% - -16130.3% | -23881.5% |